Feb 29, 2024 08:30AM
Aug 2, 2023 07:00AM
Jun 23, 2023 06:30AM
Jun 23, 2023 06:30AM
Jun 23, 2023 02:45AM
Jun 22, 2023 05:52PM
Jun 22, 2023 05:45PM Intercept Receives Complete Response Letter from FDA for Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH
Jun 7, 2023 07:01AM
Jun 7, 2023 07:00AM
May 22, 2023 11:14AM
May 22, 2023 06:56AM
May 22, 2023 06:49AM
May 20, 2023 07:32AM
May 19, 2023 06:45PM Intercept Announces Outcome of FDA Advisory Committee Meeting for Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH
May 19, 2023 07:06AM
May 19, 2023 07:05AM
May 19, 2023 07:01AM
May 19, 2023 07:00AM
May 17, 2023 03:25PM
May 17, 2023 12:06PM
May 17, 2023 09:40AM Intercept Pharma (ICPT) Declines After FDA Posts Briefing Documents Ahead of Panel for NASH Treatment
May 16, 2023 05:00PM
May 16, 2023 05:00PM
Apr 27, 2023 07:00AM
Apr 27, 2023 06:55AM
Mar 10, 2023 09:08AM
Mar 10, 2023 09:05AM
Mar 2, 2023 07:00AM Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates; Issues 2023 Financial Guidance
Jan 19, 2023 08:00AM
Jan 4, 2023 09:02AM
Jan 4, 2023 09:00AM
Dec 23, 2022 07:52AM
Dec 23, 2022 07:50AM
Dec 8, 2022 06:00PM
Nov 16, 2022 11:10AM Intercept Pharmaceuticals (ICPT) PT Lowered to $14 at H.C. Wainwright
Nov 10, 2022 09:00AM
Nov 7, 2022 08:03AM
Nov 7, 2022 08:00AM
Nov 7, 2022 05:40AM
Nov 6, 2022 08:00AM
Nov 1, 2022 07:00AM
Oct 31, 2022 04:05PM Intercept Announces New Data to be Presented in PBC, Liver Fibrosis due to NASH and Pipeline at AASLD The Liver Meeting® 2022
Sep 30, 2022 07:55AM
Sep 30, 2022 07:55AM
Sep 20, 2022 12:45PM
Sep 20, 2022 12:45PM
Aug 3, 2022 07:00AM
Jul 8, 2022 06:17AM
Jul 7, 2022 07:30AM Intercept Pharma (ICPT) Reports Positive Data in Fibrosis due to NASH from New Analysis of its Phase 3 REGENERATE Study of OCA
Jul 7, 2022 07:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All